The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.15
Bid: 17.80
Ask: 18.50
Change: -0.30 (-1.63%)
Spread: 0.70 (3.933%)
Open: 18.45
High: 0.00
Low: 0.00
Prev. Close: 18.45
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of NGSoft

1 Mar 2021 07:00

RNS Number : 6021Q
BATM Advanced Communications Ld
01 March 2021
 

LEI: 213800FLQUB9J289RU66

1 March 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Update on Sale of NGSoft

 

Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer").

 

The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021.

 

The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021.

 

NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value."

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEIFWAEFSEDE
Date   Source Headline
2nd Jul 20121:24 pmRNSResult of AGM
2nd Jul 20127:00 amRNSAGM Statement
26th Jun 20123:02 pmRNSHolding(s) in Company
7th Jun 20128:33 amRNSNotice of AGM
16th May 20128:00 amRNSHolding(s) in Company
4th May 20127:00 amRNSHolding(s) in Company
2nd May 20127:00 amRNSHCV Testing Certification
30th Apr 20124:00 pmRNSAnnual Financial Report
11th Apr 20127:00 amRNSInterim Management Statement
23rd Mar 20127:00 amRNSHIV Testing Certification
22nd Mar 20124:33 pmRNSHolding(s) in Company
15th Mar 20129:01 amRNSHolding(s) in Company
6th Mar 20122:28 pmRNSHolding(s) in Company
27th Feb 20124:03 pmRNSHolding(s) in Company
27th Feb 20123:55 pmRNSDirectorate Change
27th Feb 20127:00 amRNSFinal Results
16th Feb 20123:04 pmRNSHolding(s) in Company
13th Feb 20129:53 amRNSHolding(s) in Company
9th Feb 20128:49 amRNSHolding(s) in Company
14th Dec 201110:35 amRNSDirector/PDMR Shareholding
13th Dec 20112:00 pmRNSDirector/PDMR Shareholding
12th Dec 20112:45 pmRNSTrading Statement
24th Nov 20114:00 pmRNSHolding(s) in Company
16th Nov 20117:00 amRNSMotorola Agreement
31st Oct 201112:05 pmRNSHolding(s) in Company
26th Oct 20117:01 amRNSInterim Management Statement
26th Oct 20117:00 amRNSGlobal OEM Agreement
4th Oct 20117:00 amRNSChange of Adviser
15th Sep 20114:40 pmRNSSecond Price Monitoring Extn
15th Sep 20114:35 pmRNSPrice Monitoring Extension
12th Sep 201112:24 pmRNSHolding(s) in Company
18th Aug 20117:00 amRNSHalf Yearly Report
4th Aug 201110:00 amRNSNotice of Results
15th Jun 201112:47 pmRNSResult of AGM
15th Jun 20117:00 amRNSAGM Statement
13th May 20119:30 amRNSNotice of AGM
4th May 20117:00 amRNSInterim Management Statement
28th Apr 20115:46 pmRNSAnnual Financial Report
28th Apr 20114:35 pmRNSPrice Monitoring Extension
21st Apr 20117:00 amRNSAcquisition of ANDA
14th Apr 20119:35 amRNSHolding(s) in Company
4th Apr 201110:24 amRNSHolding(s) in Company
23rd Mar 20111:00 pmRNSHolding(s) in Company
17th Mar 201112:07 pmRNSDirector/PDMR Shareholding
15th Mar 201112:36 pmRNSHolding(s) in Company
10th Mar 201110:40 amRNSResult of General Meeting
7th Mar 201112:49 pmRNSDividend Declaration
7th Mar 20117:00 amRNSFinal Results
14th Feb 20117:00 amRNSNotice of EGM
9th Feb 20117:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.